Events | 2009.10.29
Protalix BioTherapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference
CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced today that Dr. David Aviezer, President and CEO, will present at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 1:35 PM ET. The conference is being held at the Waldorf Astoria Hotel in New York. An audio webcast of the corporate presentation will be available on Protalix’s website at www.protalix.com under the events calendar section. About Protalix BioTherapeut
For more information, please visit
http://www.businesswire.com/news/home/20091029005258/en
Follow us on
📊 Most Viewed News
- • The complete guide to making your product international - The Nex... (15,542)
- • Colaboração 2.0: Breaking Down the Language Barrier - Business ... (12,035)
- • A Start-Up Bets on Human Translators Over Machines - New York Tim... (11,530)
- • Immigrants 'should learn English' - Politics.co.uk (11,211)
- • How OpenStack gets translated - opensource.com (11,048)
- • easyJet Chooses TransPerfect for Pan-European Translation - Busin... (10,937)
- • Para-Plus Translations Honored by Philadelphia Business Journal .... (10,367)
- • Google Adds Customized Translations for Website Owners - PC Magaz... (10,257)